Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.
Pugsley MK
,
Yu EJ
,
Goldin AL
.
???displayArticle.abstract???
To determine whether the kappa opioid receptor agonist U-50,488H, a benzacetamide derivative of the cyclo-hexane-1,2-diamine analgesics, may be a useful molecular probe to define the structural requirements of this class of drugs for cardiac sodium channel blockade. The electrophysiological effects of U-50,488H were compared with those of lidocaine, a clinically used class Ib antiarrhythmic agent, in rat heart sodium currents expressed in Xenopus laevis oocytes by using two-electrode voltage clamp. Both U-50,488H and lidocaine produced a concentration-dependent tonic block of sodium current, but U-50,488H was approximately fourfold more potent than lidocaine. Both drugs produced a hyperpolarizing shift in the voltage dependence of sodium channel inactivation and both delayed recovery from inactivation. Both drugs exhibited use-dependent block, but U-50,488H showed a 1.8-fold increase in potency compared with lidocaine at a high frequency of stimulation (30 Hz). The more potent tonic and use-dependent block of cardiac sodium channels by U-50,488H suggests that structural features of this molecule may provide it with a greater ability to block the channel. An understanding of these structural features may provide information needed in the development of novel arylacetamide-based antiarrhythmic drugs and insight into possible mechanisms describing channel block, resulting in a highly efficacious antiarrhythmic action in the heart.
Bean,
Lidocaine block of cardiac sodium channels.
1983, Pubmed
Bean,
Lidocaine block of cardiac sodium channels.
1983,
Pubmed
Bokesch,
Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve.
1986,
Pubmed
Clark,
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives.
1988,
Pubmed
Courtney,
Sodium channel blockers: the size/solubility hypothesis revisited.
1990,
Pubmed
Courtney,
Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium.
1980,
Pubmed
De Luca,
Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
2000,
Pubmed
Dougherty,
Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp.
1996,
Pubmed
Ehring,
Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
1988,
Pubmed
Główka,
Spatial requirements of the Na channel binding site for class I antiarrhythmics as derived from the crystal structures of 4-substituted 2,6-bis(1-pyrrolidinylmethyl)phenols.
1991,
Pubmed
Goldin,
Preparation of RNA for injection into Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Hille,
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.
1977,
Pubmed
HODGKIN,
A quantitative description of membrane current and its application to conduction and excitation in nerve.
1952,
Pubmed
Hondeghem,
Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.
1977,
Pubmed
Isom,
Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel.
1992,
Pubmed
,
Xenbase
Kallen,
Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle.
1990,
Pubmed
Li,
A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel.
1999,
Pubmed
,
Xenbase
Liu,
Relationship between structure and sodium channel blockade by lidocaine and its amino-alkyl derivatives.
1994,
Pubmed
Noda,
Expression of functional sodium channels from cloned cDNA.
,
Pubmed
,
Xenbase
Nuss,
Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels.
1995,
Pubmed
Pugsley,
Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
1992,
Pubmed
Pugsley,
An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
1994,
Pubmed
Pugsley,
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
1998,
Pubmed
,
Xenbase
Quan,
Use-dependent inhibition of Na+ currents by benzocaine homologs.
1996,
Pubmed
Ragsdale,
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
1996,
Pubmed
Ragsdale,
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
1994,
Pubmed
,
Xenbase
Strichartz,
An integrated view of the molecular toxinology of sodium channel gating in excitable cells.
1987,
Pubmed
Szmuszkovicz,
Benzeneacetamide amines: structurally novel non-m mu opioids.
1982,
Pubmed
Valenzuela,
Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
1995,
Pubmed
Vaughan Williams,
A classification of antiarrhythmic actions reassessed after a decade of new drugs.
1984,
Pubmed
Wang,
Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
1993,
Pubmed
Wang,
Distinct local anesthetic affinities in Na+ channel subtypes.
1996,
Pubmed
Wang,
Quaternary ammonium derivative of lidocaine as a long-acting local anesthetic.
1995,
Pubmed
Yeh,
Molecular and structural basis of resting and use-dependent block of sodium current defined using disopyramide analogues.
1987,
Pubmed
Zamponi,
Open-channel block by internally applied amines inhibits activation gate closure in batrachotoxin-activated sodium channels.
1994,
Pubmed
Zamponi,
Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation.
1993,
Pubmed
